three years of REDEFINE threads, summarised so you do not have to read them
Been lurking in c/orforglipron for about 16 months and finally have something worth posting. Short version: week 70, 12.5mg, and amylin is the bit I still cannot get a straight answer on. I have read the wiki, I have read the last 3 threads, and the answers split roughly down the middle. What I actually want to know…
Every time this gets posted it hits the front page and every time someone has to re-explain it.
REDEFINE phase 18 readouts are interesting but 18 person CagriSema is different from 18 trial CagriSema.
This is correct. The co-agonism is real.
long-acting amylin is co-agonism, different satiety profile
research use only, no human protocols in posts
Yeah, amylin is doing different work than GLP-1.